ACEOMEG

Brand name authorized in: United Kingdom

Active ingredients

The drug ACEOMEG contains a combination of these active pharmaceutical ingredients (APIs):

1 Eicosapentaenoic acid
UNII AAN7QOV9EA - ICOSAPENT

Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It also has the trivial name timnodonic acid. Eicosapentaenoic acid is a polyunsaturated fatty acid (PUFA) that acts as a precursor for prostaglandin-3 (which inhibits platelet aggregation), thromboxane-3, and leukotriene-5 eicosanoids. Eicosapentaenoic acid is both a precursor and the hydrolytic breakdown product of eicosapentaenoyl ethanolamide (EPEA: C22H35NO2; 20:5,n-3).

Read about Eicosapentaenoic acid
2 Docosahexaenoic acid
UNII ZAD9OKH9JC - DOCONEXENT

Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk (breast milk), fish oil, or algae oil.

Read about Docosahexaenoic acid

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 381013